PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO)
Titel:
PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO)
Auteur:
Vinti, L. Daw, Stephen Alvarez, C. Fagioli, F. Beishuizen, A. Michel, G. Moleti, M. Cepelova, M. Thorwarth, A. Rigaud, C. de Sabando, D. Parker, J. Zhu, Y. Pillai, P. Nahar, A. Mauz-Koerholz, C.